115 related articles for article (PubMed ID: 8133400)
1. Expression of the c-erbB-3 protein in gastrointestinal tract tumours determined by monoclonal antibody RTJ1.
Rajkumar T; Gooden CS; Lemoine NR; Gullick WJ; Goden CS
J Pathol; 1993 Jul; 170(3):271-8. PubMed ID: 8133400
[TBL] [Abstract][Full Text] [Related]
2. Production and characterization of a polyclonal antibody to the c-erbB-3 protein: examination of c-erbB-3 protein expression in adenocarcinomas.
Poller DN; Spendlove I; Baker C; Church R; Ellis IO; Plowman GD; Mayer RJ
J Pathol; 1992 Nov; 168(3):275-80. PubMed ID: 1361526
[TBL] [Abstract][Full Text] [Related]
3. NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c-erbB-2 oncogene protein effective for use on formalin-fixed, paraffin-embedded tissue.
Corbett IP; Henry JA; Angus B; Watchorn CJ; Wilkinson L; Hennessy C; Gullick WJ; Tuzi NL; May FE; Westley BR
J Pathol; 1990 May; 161(1):15-25. PubMed ID: 1973458
[TBL] [Abstract][Full Text] [Related]
4. High c-erbB-3 protein expression is associated with shorter survival in advanced non-small cell lung carcinomas.
Yi ES; Harclerode D; Gondo M; Stephenson M; Brown RW; Younes M; Cagle PT
Mod Pathol; 1997 Feb; 10(2):142-8. PubMed ID: 9127320
[TBL] [Abstract][Full Text] [Related]
5. Expression of c-erbB proto-oncogene family members in squamous cell carcinoma of the head and neck.
Ibrahim SO; Vasstrand EN; Liavaag PG; Johannessen AC; Lillehaug JR
Anticancer Res; 1997; 17(6D):4539-46. PubMed ID: 9494565
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of the epidermal growth factor receptor in paraffin-embedded human tissues.
Gullick WJ; Hughes CM; Mellon K; Neal DE; Lemoine NR
J Pathol; 1991 Aug; 164(4):285-9. PubMed ID: 1681040
[TBL] [Abstract][Full Text] [Related]
7. Expression of the c-erbB-3 protein in normal human adult and fetal tissues.
Prigent SA; Lemoine NR; Hughes CM; Plowman GD; Selden C; Gullick WJ
Oncogene; 1992 Jul; 7(7):1273-8. PubMed ID: 1377811
[TBL] [Abstract][Full Text] [Related]
8. Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types.
Srinivasan R; Poulsom R; Hurst HC; Gullick WJ
J Pathol; 1998 Jul; 185(3):236-45. PubMed ID: 9771476
[TBL] [Abstract][Full Text] [Related]
9. C-erbB-2 expression in squamous cell carcinoma of the head and neck.
Field JK; Spandidos DA; Yiagnisis M; Gosney JR; Papadimitriou K; Stell PM
Anticancer Res; 1992; 12(3):613-9. PubMed ID: 1377893
[TBL] [Abstract][Full Text] [Related]
10. Lack of expression of c-erbB-2 oncoprotein in human esophageal squamous cell carcinomas.
Suo Z; Su W; Holm R; Nesland JM
Anticancer Res; 1995; 15(6B):2797-8. PubMed ID: 8669867
[TBL] [Abstract][Full Text] [Related]
11. The production and characterisation of monoclonal antibodies to myc, c-erbB-2 and EFG-receptor using a synthetic peptide approach.
Price KM; Cuthbertson AS; Varndell IM; Sheppard PW
Dev Biol Stand; 1990; 71():23-31. PubMed ID: 1698166
[TBL] [Abstract][Full Text] [Related]
12. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line.
Ethier SP; Kokeny KE; Ridings JW; Dilts CA
Cancer Res; 1996 Feb; 56(4):899-907. PubMed ID: 8631031
[TBL] [Abstract][Full Text] [Related]
13. Expression of epidermal growth factor receptor family proteins (EGFR, c-erbB-2 and c-erbB-3) in gastric cancer and chronic gastritis.
Slesak B; Harlozinska A; Porebska I; Bojarowski T; Lapinska J; Rzeszutko M; Wojnar A
Anticancer Res; 1998; 18(4A):2727-32. PubMed ID: 9703936
[TBL] [Abstract][Full Text] [Related]
14. Expression of the c-erbB-2 gene product (p185) at different stages of neoplastic progression in the colon.
D'Emilia J; Bulovas K; D'Ercole K; Wolf B; Steele G; Summerhayes IC
Oncogene; 1989 Oct; 4(10):1233-9. PubMed ID: 2571966
[TBL] [Abstract][Full Text] [Related]
15. Clinical and prognostic significance of the expression of the c-erbB-2 and c-erbB-3 oncoproteins in primary and metastatic malignant melanomas and breast carcinomas.
Bodey B; Bodey B; Gröger AM; Luck JV; Siegel SE; Taylor CR; Kaiser HE
Anticancer Res; 1997; 17(2B):1319-30. PubMed ID: 9137492
[TBL] [Abstract][Full Text] [Related]
16. The EGF receptor system in head and neck carcinomas and normal tissues. Immunohistochemical and quantitative studies.
Christensen ME
Dan Med Bull; 1998 Apr; 45(2):121-34. PubMed ID: 9587699
[TBL] [Abstract][Full Text] [Related]
17. C-erbB-2 gene product, a membrane protein commonly expressed on human fetal epithelial cells.
Mori S; Akiyama T; Yamada Y; Morishita Y; Sugawara I; Toyoshima K; Yamamoto T
Lab Invest; 1989 Jul; 61(1):93-7. PubMed ID: 2473278
[TBL] [Abstract][Full Text] [Related]
18. C-erbB-2 oncoprotein expression in operable non-small cell lung cancer.
Giatromanolaki A; Gorgoulis V; Chetty R; Koukourakis MI; Whitehouse R; Kittas C; Veslemes M; Gatter KC; Iordanoglou I
Anticancer Res; 1996; 16(2):987-93. PubMed ID: 8687165
[TBL] [Abstract][Full Text] [Related]
19. Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma.
Rubin Grandis J; Tweardy DJ; Melhem MF
Clin Cancer Res; 1998 Jan; 4(1):13-20. PubMed ID: 9516947
[TBL] [Abstract][Full Text] [Related]
20. c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival.
Giatromanolaki A; Koukourakis MI; Sivridis E; Fountzilas G
Anticancer Res; 2000; 20(2A):997-1004. PubMed ID: 10810387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
